165 related articles for article (PubMed ID: 9438863)
1. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor staurosporine.
Zhou TJ; Sun LG; Gao Y; Goldsmith EJ
Acta Biochim Biophys Sin (Shanghai); 2006 Jun; 38(6):385-92. PubMed ID: 16761096
[TBL] [Abstract][Full Text] [Related]
3. Structures of staurosporine bound to CDK2 and cAPK--new tools for structure-based design of protein kinase inhibitors.
Toledo LM; Lydon NB
Structure; 1997 Dec; 5(12):1551-6. PubMed ID: 9438871
[TBL] [Abstract][Full Text] [Related]
4. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.
Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D
Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723
[TBL] [Abstract][Full Text] [Related]
5. A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility.
Narayana N; Cox S; Nguyen-huu X; Ten Eyck LF; Taylor SS
Structure; 1997 Jul; 5(7):921-35. PubMed ID: 9261084
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
[TBL] [Abstract][Full Text] [Related]
7. Mapping substrate-induced conformational changes in cAMP-dependent protein kinase by protein footprinting.
Cheng X; Shaltiel S; Taylor SS
Biochemistry; 1998 Oct; 37(40):14005-13. PubMed ID: 9760235
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor binding to mutants of protein kinase A with GGGxxG and GxGxxA glycine-rich loop motifs.
Alam KA; Gani OASBM; Engh RA
J Mol Recognit; 2021 Apr; 34(4):e2882. PubMed ID: 33191558
[TBL] [Abstract][Full Text] [Related]
9. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
[TBL] [Abstract][Full Text] [Related]
10. Alkylation of Staurosporine to Derive a Kinase Probe for Fluorescence Applications.
Disney AJ; Kellam B; Dekker LV
ChemMedChem; 2016 May; 11(9):972-9. PubMed ID: 27008372
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
Walker EH; Pacold ME; Perisic O; Stephens L; Hawkins PT; Wymann MP; Williams RL
Mol Cell; 2000 Oct; 6(4):909-19. PubMed ID: 11090628
[TBL] [Abstract][Full Text] [Related]
12. Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme crystal structure.
Akamine P; Madhusudan ; Wu J; Xuong NH; Ten Eyck LF; Taylor SS
J Mol Biol; 2003 Mar; 327(1):159-71. PubMed ID: 12614615
[TBL] [Abstract][Full Text] [Related]
13. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002.
Jacobs MD; Black J; Futer O; Swenson L; Hare B; Fleming M; Saxena K
J Biol Chem; 2005 Apr; 280(14):13728-34. PubMed ID: 15657054
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.
Kim C; Xuong NH; Taylor SS
Science; 2005 Feb; 307(5710):690-6. PubMed ID: 15692043
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design.
Badireddy S; Yunfeng G; Ritchie M; Akamine P; Wu J; Kim CW; Taylor SS; Qingsong L; Swaminathan K; Anand GS
Mol Cell Proteomics; 2011 Mar; 10(3):M110.004390. PubMed ID: 21081668
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.
Komander D; Kular GS; Bain J; Elliott M; Alessi DR; Van Aalten DM
Biochem J; 2003 Oct; 375(Pt 2):255-62. PubMed ID: 12892559
[TBL] [Abstract][Full Text] [Related]
17. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine.
Lamers MB; Antson AA; Hubbard RE; Scott RK; Williams DH
J Mol Biol; 1999 Jan; 285(2):713-25. PubMed ID: 9878439
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
J Biol Chem; 1996 Oct; 271(42):26157-64. PubMed ID: 8824261
[TBL] [Abstract][Full Text] [Related]
19. Inhibition mechanisms of staurosporine and H7 to cAMP-dependent protein kinase through docking study.
Takagi A; Yamada Mizutani M; Tomioka N; Itai A
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):618-20. PubMed ID: 8882461
[TBL] [Abstract][Full Text] [Related]
20. Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product.
Owen DJ; Noble ME; Garman EF; Papageorgiou AC; Johnson LN
Structure; 1995 May; 3(5):467-82. PubMed ID: 7663944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
